查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576095

放射治療設備市場:各產品，各用途，各終端用戶，各地區，機會，預測，2017年～2031年

Radiotherapy Devices Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 231 Pages | 商品交期: 3-5個工作天內

價格

2024-2031年預測期間，全球放射治療設備市場規模將以5.90%的複合年增長率擴大，從2023年的64.3億美元增長到2031年的101.7億美元。放射治療設備為癌症患者提供有效的治療和症狀緩解。放射治療是推動設備需求的主要因素。此外，先進技術的引進和該領域的持續發展正在支持成長。政府的支持和投資也支持放射治療設備的使用。這些是腫瘤治療中放射治療技術的開發和採用的基礎，改變了全世界癌症患者的治療選擇。

主要放射治療設備市場對研發的投資不斷增加，促使了新技術和治療方法的開發和改進。隨著這些進入者增加產品種類和全球影響力，競爭加劇並進一步支持市場的發展。這種成長吸引了更多投資並增強了市場動力。

此外，醫療設施中放射治療設備安裝的增加預計將提高治療的準確性和速度。這些應用於患者護理的新技術為患者尋求更好的解決方案。此類新技術的引入正在支持放射治療設備市場的成長。

本報告提供全球放射治療設備市場相關調查，提供市場概要，以及各產品，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球放射治療設備市場預測，2017年～2031年

  • 市場規模的分析與預測
  • 市場佔有率分析與預測
  • 市場地圖分析，2023年
    • 各產品
    • 各用途
    • 各終端用戶
    • 各地區

第6章 北美的放射治療設備市場預測，2017年～2031年

第7章 歐洲的放射治療設備市場預測，2017年～2031年

第8章 亞太地區的放射治療設備市場預測，2017年～2031年

第9章 南美的放射治療設備市場預測，2017年～2031年

第10章 中東·非洲的放射治療設備市場預測，2017年～2031年

第11章 需求供給分析

第12章 進出口的分析

第13章 價值鏈分析

第14章 波特的五力分析

第15章 大環境分析

第16章 價格分析

第17章 市場動態

第18章 市場趨勢與發展

第19章 法規結構和革新

第20章 案例研究

第21章 競爭情形

  • 前5名市場領導者的競爭矩陣
  • 前5名參與企業的SWOT分析
  • 市場參與企業前10名的形勢
    • Varian Medical Systems, Inc.
    • BEBIG Medical GmbH
    • Toshiba Energy Systems & Solutions Corporation
    • Koninklijke Philips N.V.
    • Mitsubishi Electric Corporation
    • AngioDynamics, Inc.
    • Accuray Incorporated
    • IBA Dosimetry GmbH
    • Elekta AB
    • Brainlab AG

第22章 策略性建議

第23章 諮詢方式和免責聲明

Product Code: MX12142

Global radiotherapy devices market is projected to witness a CAGR of 5.90% during the forecast period 2024-2031, growing from USD 6.43 billion in 2023 to USD 10.17 billion in 2031. Radiotherapy devices offer effective treatment and symptom relief to cancer patients. Rising cancer cases across the globe, growing awareness about novel and promising treatments among patients and healthcare search providers, and promising outcomes delivered by radiotherapy are the key factors driving the demand for radiotherapy devices. Further, the incorporation of developed technologies and continuous developments in the area supports the growth. Government support and investments serve to boost the use of radiotherapy devices. Altogether, they form the base for the developing and adopting radiotherapy technologies in oncological treatment, thus transforming therapeutic options available worldwide for cancer patients.

Increased investments in research and development conducted by the major radiotherapy devices market led to the development of new, improved technologies and treatment alternatives. When these players increase their products and global presence, competition rises, which further propelling the market's evolution. It is such growth that draws in more investment and strengthens the momentum in the market. For instance, in October 2023, Elekta AB completed the acquisition of iCAD, Inc., which comprised the Xoft Axxent Electronic Brachytherapy System. This strategic decision empowers Elekta AB to provide enhanced electronic brachytherapy alternatives, indicating the increasing need for various cancer treatment modalities.

Furthermore, the growing installation of radiotherapy devices in medical facilities is anticipated to improve the accuracy and pace of the treatment. These new technologies adopted for treating patients look for solutions that could be better for the patient. This introduction of new technologies supports the growth of the radiotherapy devices market. For instance, in December 2022, IBA Dosimetry GmbH signed an agreement with the Ministry of Health of Spain to install ten proton therapy systems as a part of a public tender. Such a contract shows the growing importance of innovative technologies in oncology treatments.

Expanding Role of Radiotherapy Devices to Drive Market Demand

The growing incidence of cancer and the increasing demand for advanced cancer treatment are influencing the market's growth for radiotherapy devices. Increasingly, there is a rising demand for effective therapies for various malignant tumors, such as breast, lung, prostate, and colorectal. According to the World Health Organization, there were an estimated 20 million new cancer cases in 2022, and these cases are anticipated to rise. The increasing trend in cases projects a rise in patients requiring radiation therapies and sophisticated treatment methods for cancer management. In response to the growing cancer burden, governments are implementing strategies and taking initiatives to develop cancer care and encourage people to avail effective treatment options. As such, it would increase the focus on radiotherapy devices and propel growth and innovation in the cancer treatment solutions market in the forecast period. For instance, in October 2023, Elekta AB won a public tender from Ukraine's Ministry of Health to deliver Harmony linear accelerators for cancer treatment. Under this partnership, Ukrainian patients will gain access to high-end radiation therapy equipment, thus improving treatment options and driving the market forward.

Technological Advancements to Drive the Radiotherapy Device Market Growth

The radiotherapy market is expanding rapidly due to the advancements in radiological equipment, especially with the incorporation of artificial intelligence. For instance, AI algorithms in AI-powered radiotherapy devices can swiftly evaluate the new imaging data, allowing instant adjustments to the treatment regimens before or during sessions. Also, technological developments in MRI and CT scanners improve the accuracy of tumor detection during treatment. Additionally, adaptive radiotherapy systems can modify the treatment plans in response to tumor size or anatomical alterations to ensure the patient receives the optimal radiation dosage during treatment. Such technologies contribute to increased treatment efficiency for cancer patients undergoing radiotherapy, resulting in better outcomes than traditional forms of care. For instance, in September 2024, Elekta AB obtained CE marking in Europe for its AI-powered adaptive CT-linear accelerator called the Elekta Evo. It allows clinicians to choose online or offline treatment adaptation options by selecting the radiation therapy that best suits an individual cancer patient.

Increasing Government Fundings to Fuel Market Growth

Increasing government funding and initiatives are the key drivers for the radiotherapy devices market. As the global incidence rate of cancer continues to grow, governments are investing in the healthcare system to improve treatment and access to cancer care. Funds are allocated to advanced radiotherapy technologies to gradually introduce sophisticated equipment for better treatment efficacy in medical facilities. The governments allocate funding to hospitals and clinics to adopt cutting-edge technologies, improving patient outcomes and treatment services. For instance, in January 2023, The Health Minister of Wales allocated USD 116.1 million (GBP 86 million) to strengthen radiotherapy services for cancer in South Wales, United States. Funding is part of a long-term initiative to deliver cancer care in southeast Wales, with assured equipment, advanced techniques, and two additional machines to deal with rising demands for treatment. Public health campaigns, such as promotions, to increase awareness regarding cancer prevention and early presentation trigger demand for radiotherapy service delivery. Strategic partnerships between government entities and healthcare institutions encourage collaboration in improving cancer care. Government support, in turn, contributes very much to responsive and robust radiotherapy devices market benefits for both patients and the health system.

Hospitals to Dominate the Global Radiotherapy Devices Market Share

Among end-users, hospitals dominate the share of the global radiotherapy devices market. Cancer treatment has become a key focus for healthcare facilities, leading hospitals to buy more radiotherapy devices to boost patient care. The rising number of cancer cases and the need for good treatment options fuel the market trend. Hospitals invest in cutting-edge tech, such as linear accelerators and imaging systems, to give exact and quick radiation therapy. The focus on better treatment results and patient safety speeds up this uptake. Also, hospitals now use adaptive radiotherapy systems, which allow changes to treatment plans in real time to give each patient tailored care. The high demand from hospitals plays an important role in the growth of the radiotherapy devices market. For instance, in June 2024, Heidelberg University Hospital in Germany installed its new Radixact System to advance its cancer care approach. The system features ClearRT imaging, Synchrony motion tracking, and a VOLO Ultra Optimizer that delivers improved workflow, image clarity, and precision to help the hospital by serving patients more effectively.

North America to Dominate the Global Radiotherapy Device Market Share

North America is anticipated to lead the share of the radiotherapy devices market. The presence of several major players in the region is one of the critical factors. Advanced technology and robust infrastructures in healthcare intensify the growth of the market. Integration of telemedicine in radiotherapy has transformed patient care through improvement in accessibility and the adoption of a more patient-centered approach. The growing installation and deployment of radiotherapy devices in hospitals propel market growth. For instance, in June 2023, Northwell Lenox Hill Hospital became the first in New York State to implement the HyperSight imaging solution offered by Varian Medical Systems, Inc., leveraging advanced cone-beam computed tomography on its Halcyon linear accelerator for high-precision radiation therapy. This introduction aids clinicians in quickly gathering information and images during the treatment, improving the patient's experience. Also, evolving reimbursement models incentivize healthcare facilities to invest in modern radiotherapy technologies, aligning financial benefits with quality care. The growing number of radiation oncology centers is enhancing access, particularly in rural communities, and addressing treatment accessibility issues. In addition, advanced analytics and machine learning completely transform treatment planning and monitoring, ensuring more accurate and individualized approaches to therapy, which are critical in enhancing patient outcomes in cancer treatment.

Future Market Scenario (2024 - 2031F)

Advancements in radiotherapy technology hold great promise for the market. The integration of AI technology creates the opportunity to produce personalized treatment planning. Improved imaging techniques to visualize tumors better and stereotactic body radiation therapy (SBRT) development to achieve highly targeted treatment applications. Other trends include proton therapy and adaptive radiotherapy, which can adapt to real-time changes. The demand for outpatient care and combination therapies will increase in the forecast period, pushing the market for portable and user-friendly devices so that radiotherapy can reach more patients efficiently around the world. For instance, in November 2023, Henry Ford West Bloomfield Hospital introduced AI-enhanced radiation therapy for cancer treatment. This new generation improves precision and comfort and reduces side effects. Radiation oncologists can easily personalize treatments with the Ethos system and HyperSight for optimal radiation delivery to tumors and simplify the adaptive radiotherapy process for efficiency and patient care.

Key Players Landscape and Outlook

Innovation continues to shape the market for radiotherapy devices, and major players are concentrating on improvements to ensure consistency and accuracy in treatment. Companies look toward more advanced technologies such as AI integration, adaptive treatment planning, and higher-resolution imaging. With the increase in demand for more precise and efficient cancer treatments, collaborations, new launches, and innovative development will increase the competition in the market. Supply chain resilience and sustainable practices will drive the changed landscape of the dynamic market.

In August 2024, Elekta AB partnered with Liaoning Huaxing AnSheng Software Technology Co., Ltd. (AnSheng). This collaboration would enhance the market position of Elekta AB in China. Elekta AB is investing in AnSheng to improve its products and customer experience, giving precedence to vendor-neutral oncology information systems tailored for China and, in the future, improving quality and efficiency in cancer care. Moreover, in August 2023, BEBIG Medical GmbH signed an agreement with Shinva Medical Instrument Co., Ltd. to develop a long-term cooperation based on the global linear accelerator (LINAC) market. Such collaboration combines the strengths of companies in dependable hardware and easy-to-handle operating systems. In that way, LINAC technology has the potential to reach a broader population and be used more frequently.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Product and Market Intelligence
  • 4.2. Mode of Brand Awareness
  • 4.3. Factors Considered in Purchase Decisions
    • 4.3.1. Features and Other Value-added Service
    • 4.3.2. Infrastructure Compatibility
    • 4.3.3. Efficiency of Solutions
    • 4.3.4. After-Sales Support
  • 4.4. Consideration of Privacy and Regulations

5. Global Radiotherapy Devices Market Outlook, 2017-2031F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. External Beam Radiation Therapy Devices
        • 5.2.1.1.1. Advanced Linear Accelerators
          • 5.2.1.1.1.1. Gamma Knife
          • 5.2.1.1.1.2. Cyberknife
          • 5.2.1.1.1.3. TomoTherapy
          • 5.2.1.1.1.4. MRI LINAC
        • 5.2.1.1.2. Conventional Linear Accelerators
        • 5.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
        • 5.2.1.1.4. Proton Therapy Devices
          • 5.2.1.1.4.1. Cyclotrons
          • 5.2.1.1.4.2. Synchrotron
          • 5.2.1.1.4.3. Synchrocyclotron
      • 5.2.1.2. Internal Beam Radiation Therapy Devices
        • 5.2.1.2.1. Brachytherapy Devices
        • 5.2.1.2.2. Consumables
      • 5.2.1.3. Others
    • 5.2.2. By Application
      • 5.2.2.1. Lung Cancer
      • 5.2.2.2. Breast Cancer
      • 5.2.2.3. Prostate Cancer
      • 5.2.2.4. Head and Neck Cancer
      • 5.2.2.5. Other Applications
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Ambulatory Surgical Centers
      • 5.2.3.3. Cancer Care Centers
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 5.3. Market Map Analysis, 2023
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Radiotherapy Devices Market Outlook, 2017-2031F*

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
    • 6.1.2. By Volume
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. Product
      • 6.2.1.1. External Beam Radiation Therapy Devices
        • 6.2.1.1.1. Advanced Linear Accelerators
          • 6.2.1.1.1.1. Gamma Knife
          • 6.2.1.1.1.2. Cyberknife
          • 6.2.1.1.1.3. TomoTherapy
          • 6.2.1.1.1.4. MRI LINAC
        • 6.2.1.1.2. Conventional Linear Accelerators
        • 6.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
        • 6.2.1.1.4. Proton Therapy Devices
          • 6.2.1.1.4.1. Cyclotrons
          • 6.2.1.1.4.2. Synchrotron
          • 6.2.1.1.4.3. Synchrocyclotron
      • 6.2.1.2. Internal Beam Radiation Therapy Devices
        • 6.2.1.2.1. Brachytherapy Devices
        • 6.2.1.2.2. Consumables
      • 6.2.1.3. Others
    • 6.2.2. By Application
      • 6.2.2.1. Lung Cancer
      • 6.2.2.2. Breast Cancer
      • 6.2.2.3. Prostate Cancer
      • 6.2.2.4. Head and Neck Cancer
      • 6.2.2.5. Other Applications
    • 6.2.3. By End-user
      • 6.2.3.1. Hospitals
      • 6.2.3.2. Ambulatory Surgical Centers
      • 6.2.3.3. Cancer Care Centers
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Radiotherapy Devices Market Outlook, 2017-2031F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
        • 6.3.1.1.2. By Volume
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. Product
          • 6.3.1.2.1.1. External Beam Radiation Therapy Devices
          • 6.3.1.2.1.1.1. Advanced Linear Accelerators
          • 6.3.1.2.1.1.1.1. Gamma Knife
          • 6.3.1.2.1.1.1.2. Cyberknife
          • 6.3.1.2.1.1.1.3. TomoTherapy
          • 6.3.1.2.1.1.1.4. MRI LINAC
          • 6.3.1.2.1.1.2. Conventional Linear Accelerators
          • 6.3.1.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
          • 6.3.1.2.1.1.4. Proton Therapy Devices
          • 6.3.1.2.1.1.4.1. Cyclotrons
          • 6.3.1.2.1.1.4.2. Synchrotron
          • 6.3.1.2.1.1.4.3. Synchrocyclotron
          • 6.3.1.2.1.2. Internal Beam Radiation Therapy Devices
          • 6.3.1.2.1.2.1. Brachytherapy Devices
          • 6.3.1.2.1.2.2. Consumables
          • 6.3.1.2.1.3. Others
        • 6.3.1.2.2. By Application
          • 6.3.1.2.2.1. Lung Cancer
          • 6.3.1.2.2.2. Breast Cancer
          • 6.3.1.2.2.3. Prostate Cancer
          • 6.3.1.2.2.4. Head and Neck Cancer
          • 6.3.1.2.2.5. Other Applications
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Hospitals
          • 6.3.1.2.3.2. Ambulatory Surgical Centers
          • 6.3.1.2.3.3. Cancer Care Centers
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Radiotherapy Devices Market Outlook, 2017-2031F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Radiotherapy Devices Market Outlook, 2017-2031F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Radiotherapy Devices Market Outlook, 2017-2031F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Radiotherapy Devices Market Outlook, 2017-2031F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework and Innovation

  • 19.1. Regulatory Approvals

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Varian Medical Systems, Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. BEBIG Medical GmbH
    • 21.3.3. Toshiba Energy Systems & Solutions Corporation
    • 21.3.4. Koninklijke Philips N.V.
    • 21.3.5. Mitsubishi Electric Corporation
    • 21.3.6. AngioDynamics, Inc.
    • 21.3.7. Accuray Incorporated
    • 21.3.8. IBA Dosimetry GmbH
    • 21.3.9. Elekta AB
    • 21.3.10. Brainlab AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Radiotherapy Devices Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Radiotherapy Devices Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Radiotherapy Devices Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 42. France Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 43. France Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Radiotherapy Devices Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Radiotherapy Devices Market Share (%), By Country, 2017-2031F
  • Figure 101. India Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 104. India Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 105. India Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 109. China Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 110. China Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Radiotherapy Devices Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Radiotherapy Devices Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Radiotherapy Devices Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023